Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
85.13
+1.04 (+1.24%)
Official Closing Price
Updated: 7:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edwards Lifesciences
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
20
21
Next >
Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint
↗
May 14, 2024
Edwards Lifesciences faces EU antitrust complaint from Meril over patent disputes, intensifying regulatory scrutiny. Recent actions aim to ensure fair competition, affordability, as Meril alleges...
Via
Benzinga
Topics
Intellectual Property
Is It Time To Get Defensive With Healthcare Stocks?
↗
May 13, 2024
Based in Irvine, California, Edwards Lifesciences is a prominent American medical technology firm.
Via
Talk Markets
Assessing Edwards Lifesciences: Insights From 11 Financial Analysts
↗
May 07, 2024
Via
Benzinga
Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy'
↗
May 01, 2024
Cramer likes Delta Air Lines, United Airlines Holdings. "Now, remember, they're very inexpensive stocks, but they trade wildly. But I do like Delta," he added.
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today
↗
April 26, 2024
Via
Benzinga
Decoding Edwards Lifesciences's Options Activity: What's the Big Picture?
↗
April 25, 2024
Via
Benzinga
Behind the Scenes of Edwards Lifesciences's Latest Options Trends
↗
April 18, 2024
Via
Benzinga
$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
↗
April 12, 2024
Via
Benzinga
How Is The Market Feeling About Edwards Lifesciences?
↗
April 12, 2024
Via
Benzinga
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
↗
April 26, 2024
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.
Via
Investor's Business Daily
EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024
↗
April 25, 2024
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff
↗
April 25, 2024
The company also raised its outlook for the year and now expects 8% to 10% sales growth.
Via
Investor's Business Daily
Edwards Lifesciences Reports First Quarter Results
April 25, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
What Analysts Are Saying About Edwards Lifesciences Stock
↗
April 11, 2024
Via
Benzinga
$100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth This Much Today
↗
April 02, 2024
Via
Benzinga
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
April 18, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
The 5 Stocks Most Sold By Insiders This Year
April 16, 2024
Insiders are selling these 5 stocks increased as their markets advanced, and gains may be capped. Long-term outlooks are positive for growth and share prices.
Via
MarketBeat
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
April 07, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
The Latest Analyst Ratings For Edwards Lifesciences
↗
March 26, 2024
Via
Benzinga
What 9 Analyst Ratings Have To Say About Edwards Lifesciences
↗
March 07, 2024
Via
Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
↗
February 27, 2024
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,200 Today
↗
February 12, 2024
Via
Benzinga
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
↗
March 19, 2024
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
↗
March 14, 2024
Via
Benzinga
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
March 11, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
February 23, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
↗
February 22, 2024
Via
Benzinga
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
↗
February 12, 2024
FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document.
Via
Benzinga
Can financial, healthcare, energy stocks rise as rates stay high?
February 08, 2024
Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024.
Via
MarketBeat
These Analysts Boost Their Forecasts On Edwards Lifesciences Following Q4 Results
↗
February 07, 2024
Edwards Lifesciences Corporation (NYSE: EW) reported in-line earnings for its fourth quarter on Tuesday.
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today